Advances in therapeutics: Converting enzyme inhibition and the kidney
- 27 September 1985
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 79 (3) , 1-2
- https://doi.org/10.1016/0002-9343(85)90072-5
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Hypertensive crisis in systemic sclerosis: treatment with the new oral angiotensin converting enzyme inhibitor mk 421 (enalapril) in captopril‐intolerant patientsArthritis & Rheumatism, 1984
- Correction of Dilutional Hyponatremia in Severe Chronic Heart Failure by Converting-Enzyme InhibitionAnnals of Internal Medicine, 1984
- Renal Response to Captopril in Severe Heart Failure: Role of Furosemide in Natriuresis and Reversal of HyponatremiaAnnals of Internal Medicine, 1984
- CaptoprilDrugs, 1983
- Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension.British Journal of Clinical Pharmacology, 1982
- Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide.Published by Wiley ,1982
- Vasoconstriction-volume analysis for understanding and treating hypertension: The use of renin and aldosterone profilesThe American Journal of Medicine, 1973